Oseltamivir
Oseltamivir is an antiviral medicine (a neuraminidase inhibitor) used to treat influenza (flu) A and B and to help prevent flu in people exposed to it, sold as capsules and as an oral suspension (liquid).
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 85 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
Oseltamivir (Tamiflu), the most familiar flu antiviral and the usual first choice, blocks an enzyme the flu virus needs to spread, treating influenza A and B when started within 48 hours of symptoms and helping prevent flu after exposure; on the market since about 1999, it is available as a generic. Most people tolerate it well, and nausea or vomiting is what people notice most. Stop it and get help for any allergic reaction or blistering rash, and watch for confusion or unusual behavior, especially in children, since flu itself can also cause this. It works alongside the yearly flu vaccine, never instead of it.
Clinical pearls
- Taking it with food or milk can ease nausea, and food does not cut how much medicine is absorbed.
- Skip the nasal spray flu vaccine from 2 weeks before until 48 hours after oseltamivir; flu shots are fine anytime.
- Doses are lowered for reduced kidney function, and it is not recommended in end-stage kidney disease without dialysis.
- If flu symptoms worsen or new ones appear, call your doctor, since a bacterial infection can develop with or after flu.
Patient information guide A plain-language walkthrough of Oseltamivir, written from its FDA label.
What Oseltamivir is used for
▾
Oseltamivir is used for influenza in these ways:
- Treating acute, uncomplicated influenza A and B in people 2 weeks and older with symptoms for no more than 48 hours (capsule and oral suspension products, including Tamiflu).
- Preventing influenza A and B in people 1 year and older (capsule and oral suspension products, including Tamiflu).
- It is not a substitute for the yearly flu vaccine.
How Oseltamivir works
▾
Oseltamivir is an influenza neuraminidase inhibitor, an antiviral with activity against influenza virus. Your body converts it, mostly in the liver, into its active form, oseltamivir carboxylate.
Flu viruses change over time, and resistance could make the drug less effective. Prescribers consider local information on flu virus susceptibility when choosing it.
Oseltamivir dosage
▾
Oseltamivir is taken by mouth as a capsule or a liquid suspension.
- Treatment: generally twice daily for 5 days.
- Prevention: generally once daily for at least 10 days, or up to 6 weeks during a community outbreak.
- Food does not significantly change how much medicine is absorbed.
- Doses depend on age, weight and kidney function. Follow your prescriber and the pharmacy label.
Dosing details from the FDA-approved label
From the Oseltamivir prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.
- Treatment of influenza: adults and adolescents (13 years and older)
- 75 mg twice daily (12.5 mL of oral suspension twice daily) for 5 days
- Initiate within 48 hours of symptom onset; may be taken with or without food, tolerability may be enhanced with food
- Treatment of influenza: pediatric patients 1 to 12 years of age
- Based on weight, twice daily for 5 days: 15 kg or less 30 mg
- 15.1 kg to 23 kg 45 mg
- 23.1 kg to 40 kg 60 mg
- 40.1 kg or more 75 mg
- Weight-based; oral suspension volumes 5 mL, 7.5 mL, 10 mL, 12.5 mL respectively
- Treatment of influenza: pediatric patients 2 weeks to less than 1 year of age
- 3 mg/kg twice daily for 5 days (0.5 mL/kg of 6 mg/mL oral suspension)
- Weight-based; use a dosing device that can accurately measure small volumes
- Treatment of influenza: renally impaired adults (creatinine clearance >30 to 60 mL/min)
- 30 mg twice daily for 5 days
- Renal dose reduction
- Treatment of influenza: renally impaired adults (creatinine clearance >10 to 30 mL/min)
- 30 mg once daily for 5 days
- Renal dose reduction
- Treatment of influenza: ESRD patients on hemodialysis
- 30 mg immediately and then 30 mg after every hemodialysis cycle
- Maximum: Treatment duration not to exceed 5 days
- Renal dose reduction
- Treatment of influenza: ESRD patients on CAPD
- Single 30 mg dose immediately
- Renal dose reduction
- Prophylaxis of influenza: adults and adolescents (13 years and older)
- 75 mg once daily (12.5 mL of oral suspension) for at least 10 days following close contact
- Community outbreak: up to 6 weeks
- Maximum: Up to 12 weeks in immunocompromised patients
- Start post-exposure prophylaxis within 48 hours of close contact
- Prophylaxis of influenza: pediatric patients 1 to 12 years of age
- Based on weight, once daily for 10 days: 15 kg or less 30 mg
- 15.1 kg to 23 kg 45 mg
- 23.1 kg to 40 kg 60 mg
- 40.1 kg or more 75 mg
- Community outbreak: up to 6 weeks
- Weight-based; oral suspension volumes 5 mL, 7.5 mL, 10 mL, 12.5 mL respectively
- Prophylaxis of influenza: renally impaired adults (creatinine clearance >30 to 60 mL/min)
- 30 mg once daily
- Renal dose reduction; >10 to 30 mL/min: 30 mg once every other day; hemodialysis: 30 mg immediately then 30 mg after alternate hemodialysis cycles; CAPD: 30 mg immediately then 30 mg once weekly
Read the label’s full dosing text
2 DOSAGE AND ADMINISTRATION Treatment of influenza Adults and adolescents (13 years and older): 75 mg twice daily for 5 days ( 2.2 ) Pediatric patients 1 to 12 years of age: Based on weight twice daily for 5 days ( 2.2 ) Pediatric patients 2 weeks to less than 1 year of age: 3 mg/kg twice daily for 5 days ( 2.2 ) Renally impaired adult patients (creatinine clearance >30 to 60 mL/min): Reduce to 30 mg twice daily for 5 days ( 2.4 ) Renally impaired adult patients (creatinine clearance >10 to 30 mL/min): Reduce to 30 mg once daily for 5 days ( 2.4 ) ESRD patients on hemodialysis: Reduce to 30 mg immediately and then 30 mg after every hemodialysis cycle. Treatment duration not to exceed 5 days ( 2.4 ) ESRD patients on CAPD: Reduce to a single 30 mg dose immediately ( 2.4 ) Prophylaxis of influenza Adults and adolescents (13 years and older): 75 mg once daily for at least 10 days ( 2.3 ) Community outbreak: 75 mg once daily for up to 6 weeks ( 2.3 ) Pediatric patients 1 to 12 years of age: Based on weight once daily for 10 days ( 2.3 ) Community outbreak: Based on weight once daily for up to 6 weeks ( 2.3 ) Renally impaired adult patients (creatinine clearance >30 to 60 mL/min): Reduce to 30 mg once daily ( 2.4 ) Renally impaired adult patients (creatinine clearance >10 to 30 mL/min): Reduce to 30 mg once every other day ( 2.4 ) ESRD patients on hemodialysis: Reduce to 30 mg immediately and then 30 mg after alternate hemodialysis cycles for the recommended duration of prophylaxis ( 2.4 ) ESRD patients on CAPD: Reduce to 30 mg immediately and then 30 mg once weekly for the recommended duration of prophylaxis ( 2.4 ) 2.1 Dosage and Administration Overview Administer oseltamivir phosphate for oral suspension for the treatment of influenza in patients 2 weeks of age or older [see Dosage and Administration ( 2.2 )] or for prophylaxis of influenza in patients 1 year and older [see Dosage and Administration ( 2.3 )] using: Oseltamivir phosphate for oral suspension (supplied as a powder). This is the preferred formulation (6 mg per mL) for patients who cannot swallow capsules. Prior to use, the supplied oseltamivir phosphate for oral suspension powder must be constituted with water by the pharmacist to produce the oral suspension [see Dosage and Administration ( 2.5 )] .
Excerpted — the section continues on the label. Read the full Dosage and Administration section on DailyMed →
Oseltamivir side effects
▾
The most common side effects are:
Common side effects
- Nausea
- Vomiting
- Headache
- Pain (seen in prevention studies)
When to get medical help
- Get emergency help for signs of a severe allergic reaction, such as swelling, trouble breathing, or a serious skin rash or blistering.
- Stop the medicine and call your doctor right away if you develop a skin rash or other allergic-like symptoms.
- Call your doctor if you or your child has confusion, hallucinations, or unusual or abnormal behavior.
- Call your doctor if flu symptoms get worse or new symptoms appear, since a bacterial infection can happen with or after the flu.
These usually happened on the first or second day and went away on their own within 1 to 2 days. Seek help for allergic or skin reactions or unusual behavior.
Oseltamivir warnings and precautions
▾
- Serious allergic and skin reactions such as anaphylaxis, Stevens-Johnson syndrome and toxic epidermal necrolysis have been reported. Stop the medicine and get help.
- Neuropsychiatric events: delirium and abnormal behavior, mostly in children, have been reported with the flu and in people taking oseltamivir. Monitor for unusual behavior.
- Bacterial infections: oseltamivir does not treat or prevent them, and they can occur with the flu.
- Fructose intolerance: the oral suspension contains sorbitol.
Oseltamivir interactions
▾
Few drug interactions are known, but vaccines matter.
- Nasal spray flu vaccine (live attenuated): avoid within 2 weeks before or 48 hours after oseltamivir, because it may reduce the vaccine's effectiveness.
- Flu shot (inactivated): can be given at any time.
- No dose changes are needed with amoxicillin, acetaminophen, aspirin, cimetidine, antacids, rimantadine, amantadine or warfarin.
Interactions listed in the FDA-approved label
From the Oseltamivir prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
- Live attenuated influenza vaccine (LAIV), intranasal: Oseltamivir may inhibit replication of the live vaccine virus and possibly reduce the efficacy of LAIV; concurrent use has not been evaluated. Avoid administration of LAIV within 2 weeks before or 48 hours after oseltamivir, unless medically indicated.
- Inactivated influenza vaccine: No interaction stated; it can be administered at any time relative to oseltamivir use. Can be administered at any time relative to oseltamivir.
- Amoxicillin, acetaminophen, aspirin, cimetidine, antacids (magnesium and aluminum hydroxides and calcium carbonates), rimantadine, amantadine, or warfarin: No clinically significant drug interaction. No dose adjustments are needed for either oseltamivir or the concomitant drug.
Read the label’s full interactions text
7 DRUG INTERACTIONS Live attenuated influenza vaccine (LAIV), intranasal: Avoid administration of LAIV within 2 weeks before or 48 hours after Oseltamivir Phosphate for Oral Suspension use, unless medically indicated. ( 7 ) 7.1 Influenza Vaccines Live Attenuated Influenza Vaccine The concurrent use of Oseltamivir Phosphate with live attenuated influenza vaccine (LAIV) intranasal has not been evaluated. However, because of the potential for Oseltamivir Phosphate to inhibit replication of live vaccine virus and possibly reduce the efficacy of LAIV, avoid administration of LAIV within 2 weeks before or 48 hours after Oseltamivir Phosphate administration, unless medically indicated. Inactivated Influenza Vaccine Inactivated influenza vaccine can be administered at any time relative to use of Oseltamivir Phosphate. 7.2 Drugs Without Clinically Significant Drug Interaction with Oseltamivir Phosphate for Oral Suspension No dose adjustments are needed for either Oseltamivir or the concomitant drug when coadministering Oseltamivir with amoxicillin, acetaminophen, aspirin, cimetidine, antacids (magnesium and aluminum hydroxides and calcium carbonates), rimantadine, amantadine, or warfarin [see Clinical Pharmacology ( 12.3 )] .
7.1 Influenza Vaccines Live Attenuated Influenza Vaccine The concurrent use of Oseltamivir Phosphate with live attenuated influenza vaccine (LAIV) intranasal has not been evaluated. However, because of the potential for Oseltamivir Phosphate to inhibit replication of live vaccine virus and possibly reduce the efficacy of LAIV, avoid administration of LAIV within 2 weeks before or 48 hours after Oseltamivir Phosphate administration, unless medically indicated. Inactivated Influenza Vaccine Inactivated influenza vaccine can be administered at any time relative to use of Oseltamivir Phosphate.
Excerpted — the section continues on the label. Read the full Drug Interactions section on DailyMed →
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before taking Oseltamivir
▾
- Do not use if you have had a serious allergic reaction to oseltamivir or its ingredients.
- Kidney disease: doses are adjusted for reduced kidney function, and it is not recommended for end-stage kidney disease without dialysis.
- Severe liver impairment has not been studied.
- Pregnancy: studies have not shown a higher risk of birth defects, though they have limits. Flu itself is riskier in pregnancy.
- Breastfeeding: low levels pass into milk and are unlikely to harm the baby.
- Children: approved for treatment from 2 weeks and prevention from 1 year.
- Older adults: no overall differences in safety or effectiveness.
Oseltamivir overdose
▾
Overdoses have been reported, and most people had no side effects. When effects did occur, they were similar to the usual side effects. Call your doctor or poison control if too much is taken.
How your body processes Oseltamivir
▾
Oseltamivir is absorbed from the gut and converted mostly by liver enzymes into its active form, oseltamivir carboxylate. At least 75% of an oral dose reaches the bloodstream as the active form.
The active form has a half-life of about 6 to 10 hours and is cleared almost entirely by the kidneys. That is why kidney problems raise drug levels and call for lower doses.
How to store Oseltamivir
▾
Store at 20° to 25°C (68° to 77°F); Excursions permitted to 15° to 30°C (59° to 86°F) .
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
Supplements & herbs that interact with Oseltamivir
22 supplements and herbal products have documented interactions with Oseltamivir in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 1
- Moderate · 11
- Minor · 10
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Oseltamivir: pharmacist answers to common questions
Quick, plain-English answers to the questions patients ask most about Oseltamivir — the kind of thing our pharmacy team would talk through with you at the counter.
What is oseltamivir for?
▾
How do I take it?
▾
What side effects should I expect?
▾
Can I get a flu vaccine while taking it?
▾
Is it safe in pregnancy or while breastfeeding?
▾
Do I need to watch my child more closely?
▾
Is Oseltamivir available over the counter?
▾
When was Oseltamivir first available?
▾
Who makes Oseltamivir?
▾
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
More about Oseltamivir on HelloPharmacist
Oseltamivir forms and strengths (how it comes)
Oseltamivir is available in 2 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Oseltamivir inactive ingredients by manufacturer.
Capsule
How this form is used
- Tamiflu capsules are used to treat acute, uncomplicated influenza A and B in people 2 weeks and older who have had symptoms for no more than 48 hours.
- Tamiflu capsules are used to prevent influenza A and B in people 1 year and older.
- Tamiflu capsules are taken by mouth.
- Oseltamivir phosphate capsules are generally taken twice daily for 5 days for treatment and once daily for prevention, per your prescriber.
Oral suspension
How this form is used
- Oseltamivir Phosphate for Oral Suspension is used to treat acute, uncomplicated influenza A and B in people 2 weeks and older who have had symptoms for no more than 48 hours.
- Oseltamivir Phosphate for Oral Suspension is used to prevent influenza A and B in people 1 year and older.
- Oseltamivir Phosphate for Oral Suspension is taken by mouth; dosing for children is based on weight.
- Oseltamivir Phosphate for Oral Suspension contains sorbitol, which can be a problem for people with hereditary fructose intolerance.
Oseltamivir on the U.S. market: products, makers and brands
How Oseltamivir appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
36 companies list 122 Oseltamivir product records with the FDA, mostly as capsule, oral suspension; the earliest marketing or approval year on record is 1999. Brand names on the directory include Tamiflu; the rest are generics.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (19) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How widely Oseltamivir is used (Medicaid data)
A general measure of how commonly Oseltamivir is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Oseltamivir is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Oseltamivir prescribed? Of the 1,601 medications we measure, Oseltamivir ranks #95 by Medicaid prescriptions — more than 94% of them.
Utilization by Oseltamivir product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
oseltamivir 6 MG/ML Oral Suspension Most dispensed
Summed across the 12 of 34 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1115698
oseltamivir 75 MG Oral Capsule
Summed across the 14 of 85 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 312122
oseltamivir 30 MG Oral Capsule
Summed across the 12 of 38 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 728109
oseltamivir 45 MG Oral Capsule
Summed across the 11 of 42 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 728113
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Oseltamivir, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 49 of 199 listed Oseltamivir NDCs with Medicaid activity.
Compare Oseltamivir products
A representative set of FDA-listed product records for Oseltamivir — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Capsule | ||||
| 75 mg | Oral | A-S Medication Solutions × 4 listings | ANDA | View NDC → |
| 30 mg | Oral | Alembic Pharmaceuticals Inc. | ANDA | View NDC → |
| 45 mg | Oral | Alembic Pharmaceuticals Inc. | ANDA | View NDC → |
| 75 mg | Oral | Alembic Pharmaceuticals Inc. | ANDA | View NDC → |
| 30 mg | Oral | Alembic Pharmaceuticals Limited | ANDA | View NDC → |
| 45 mg | Oral | Alembic Pharmaceuticals Limited | ANDA | View NDC → |
| 75 mg | Oral | Alembic Pharmaceuticals Limited | ANDA | View NDC → |
| 30 mg | Oral | Alvogen Inc. | ANDA | View NDC → |
| 45 mg | Oral | Alvogen Inc. | ANDA | View NDC → |
| 75 mg | Oral | Alvogen Inc. | ANDA | View NDC → |
| 30 mg | Oral | Amneal Pharmaceuticals NY LLC × 2 listings | ANDA | View NDC → |
| 45 mg | Oral | Amneal Pharmaceuticals NY LLC × 2 listings | ANDA | View NDC → |
| 75 mg | Oral | Amneal Pharmaceuticals NY LLC × 2 listings | ANDA | View NDC → |
| 30 mg | Oral | Asclemed USA, Inc. | ANDA | View NDC → |
| 45 mg | Oral | Asclemed USA, Inc. | ANDA | View NDC → |
| 75 mg | Oral | Asclemed USA, Inc. × 2 listings | ANDA | View NDC → |
| 30 mg | Oral | AvKARE | ANDA | View NDC → |
| 75 mg | Oral | AvKARE | ANDA | View NDC → |
| 30 mg | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 45 mg | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 75 mg | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 30 mg | Oral | Epic Pharma, Llc | ANDA | View NDC → |
| 45 mg | Oral | Epic Pharma, Llc | ANDA | View NDC → |
| 75 mg | Oral | Epic Pharma, Llc | ANDA | View NDC → |
| 30 mg | Oral | Exelan Pharmaceuticals, Inc. | ANDA | View NDC → |
| 45 mg | Oral | Exelan Pharmaceuticals, Inc. | ANDA | View NDC → |
| 75 mg | Oral | Exelan Pharmaceuticals, Inc. | ANDA | View NDC → |
| 30 mg | Oral | Genentech, Inc. | NDA | View NDC → |
| 75 mg | Oral | Genentech, Inc. | NDA | View NDC → |
| 30 mg | Oral | Lannett Company, Inc. | ANDA | View NDC → |
| 45 mg | Oral | Lannett Company, Inc. | ANDA | View NDC → |
| 75 mg | Oral | Lannett Company, Inc. | ANDA | View NDC → |
| 30 mg | Oral | Laurus Labs Limited | ANDA | View NDC → |
| 45 mg | Oral | Laurus Labs Limited | ANDA | View NDC → |
| 75 mg | Oral | Laurus Labs Limited | ANDA | View NDC → |
| 30 mg | Oral | Lupin Pharmaceuticals, Inc. | ANDA | View NDC → |
| 45 mg | Oral | Lupin Pharmaceuticals, Inc. | ANDA | View NDC → |
| 75 mg | Oral | Lupin Pharmaceuticals, Inc. | ANDA | View NDC → |
| 30 mg | Oral | Macleods Pharmaceuticals Limited | ANDA | View NDC → |
| 45 mg | Oral | Macleods Pharmaceuticals Limited | ANDA | View NDC → |
| 75 mg | Oral | Macleods Pharmaceuticals Limited | ANDA | View NDC → |
| 45 mg | Oral | Msn Laboratories Private Limited | ANDA | View NDC → |
| 30 mg | Oral | Novadoz Pharmaceuticals LLC | ANDA | View NDC → |
| 45 mg | Oral | Novadoz Pharmaceuticals LLC | ANDA | View NDC → |
| 75 mg | Oral | Novadoz Pharmaceuticals LLC | ANDA | View NDC → |
| 75 mg | Oral | Preferred Pharmaceuticals Inc. × 4 listings | ANDA | View NDC → |
| 30 mg | Oral | Proficient Rx LP × 2 listings | ANDA | View NDC → |
| 45 mg | Oral | Proficient Rx LP × 2 listings | ANDA | View NDC → |
| 75 mg | Oral | Proficient Rx LP × 4 listings | ANDA | View NDC → |
| 30 mg | Oral | Redpharm Drug | ANDA | View NDC → |
| 75 mg | Oral | Redpharm Drug × 2 listings | ANDA | View NDC → |
| 75 mg | Oral | Remedyrepack Inc. × 2 listings | ANDA | View NDC → |
| 30 mg | Oral | Shandong New Time Pharmaceutical Co., Ltd. | ANDA | View NDC → |
| 45 mg | Oral | Shandong New Time Pharmaceutical Co., Ltd. | ANDA | View NDC → |
| 75 mg | Oral | Shandong New Time Pharmaceutical Co., Ltd. | ANDA | View NDC → |
| 75 mg | Oral | Slate Run Pharmaceuticals, LLC | ANDA | View NDC → |
| 30 mg | Oral | Sportpharm LLC × 2 listings | ANDA | View NDC → |
| 45 mg | Oral | Sportpharm LLC × 2 listings | ANDA | View NDC → |
| 75 mg | Oral | Sportpharm LLC × 2 listings | ANDA | View NDC → |
| 30 mg | Oral | Strides Pharma Science Limited | ANDA | View NDC → |
| 45 mg | Oral | Strides Pharma Science Limited | ANDA | View NDC → |
| 75 mg | Oral | Strides Pharma Science Limited | ANDA | View NDC → |
| 30 mg | Oral | Zhejiang Poly Pharm. Co., Ltd. | ANDA | View NDC → |
| 45 mg | Oral | Zhejiang Poly Pharm. Co., Ltd. | ANDA | View NDC → |
| 75 mg | Oral | Zhejiang Poly Pharm. Co., Ltd. | ANDA | View NDC → |
| 30 mg | Oral | Zydus Lifesciences Limited | ANDA | View NDC → |
| 45 mg | Oral | Zydus Lifesciences Limited | ANDA | View NDC → |
| 75 mg | Oral | Zydus Lifesciences Limited | ANDA | View NDC → |
| 30 mg | Oral | Zydus Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 45 mg | Oral | Zydus Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 75 mg | Oral | Zydus Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 💊Oral suspension | ||||
| 6 mg/mL | Oral | A-S Medication Solutions × 3 listings | ANDA | View NDC → |
| 6 mg/mL | Oral | Ajanta Pharma USA Inc. | ANDA | View NDC → |
| 6 mg/mL | Oral | Alembic Pharmaceuticals Inc. | ANDA | View NDC → |
| 6 mg/mL | Oral | Alembic Pharmaceuticals Limited | ANDA | View NDC → |
| 6 mg/mL | Oral | Alvogen Inc. | ANDA | View NDC → |
| 6 mg/mL | Oral | Amneal Pharmaceuticals NY LLC | ANDA | View NDC → |
| 6 mg/mL | Oral | Asclemed USA, Inc. | ANDA | View NDC → |
| 6 mg/mL | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| 6 mg/mL | Oral | AvKARE | ANDA | View NDC → |
| 6 mg/mL | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 6 mg/mL | Oral | Cipla USA, Inc | ANDA | View NDC → |
| 6 mg/mL | Oral | Epic Pharma, Llc | ANDA | View NDC → |
| 6 mg/mL | Oral | Exelan Pharmaceuticals, Inc. | ANDA | View NDC → |
| 6 mg/mL | Oral | Genentech, Inc. | NDA | View NDC → |
| 6 mg/mL | Oral | HEC Pharm USA Inc. | ANDA | View NDC → |
| 6 mg/mL | Oral | Lannett Company, Inc. | ANDA | View NDC → |
| 6 mg/mL | Oral | Leading Pharma, LLC | ANDA | View NDC → |
| 6 mg/mL | Oral | Lupin Pharmaceuticals, Inc. | ANDA | View NDC → |
| 6 mg/mL | Oral | Novadoz Pharmaceuticals LLC | ANDA | View NDC → |
| 6 mg/mL | Oral | NuCare Pharmaceuticals, Inc. | ANDA | View NDC → |
| 6 mg/mL | Oral | NuCare Pharmaceuticals,Inc. | ANDA | View NDC → |
| 6 mg/mL | Oral | Oryza Pharmaceuticals Inc. | ANDA | View NDC → |
| 6 mg/mL | Oral | Preferred Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 6 mg/mL | Oral | Proficient Rx LP | ANDA | View NDC → |
| 6 mg/mL | Oral | Strides Pharma Science Limited | ANDA | View NDC → |
| 6 mg/mL | Oral | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| 6 mg/mL | Oral | Zydus Lifesciences Limited | ANDA | View NDC → |
| 6 mg/mL | Oral | Zydus Pharmaceuticals USA Inc. | ANDA | View NDC → |
Showing 122 of 122 products — FDA National Drug Code Directory. See every product, package size and price: browse all 122 Oseltamivir NDCs →
Oseltamivir side effects reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Oseltamivir — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Oseltamivir in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Oseltamivir FDA approval history
How Oseltamivir went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Oseltamivir recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list one Oseltamivir recall since July 2021. It is no longer listed as ongoing. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.
- Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC# 69238-1273-6 Lots: Lot # BF22722A, Exp. 08/31/2024; BJ15122A, Exp. 09/30/2024 FDA record D-0327-2024 →
Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 260101 2 dose forms · 5 strengths
-
Dose form (SCDF) Oral Capsule RxCUI 374615In current FDA listings -
Dose form (SCDF) Oral Suspension RxCUI 375196In current FDA listings
Look up RxCUI 260101 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Oseltamivir supply and shortage status
Whether Oseltamivir is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
💵 What Oseltamivir costs pharmacies (NADAC benchmark)
The national average invoice price pharmacies pay for the drug itself, from CMS's NADAC survey (data as of Sep 30, 2026). This is a supply-cost benchmark — not a retail price and not what you'd pay at the counter.
| Form | Strength | Pharmacy acquisition benchmark | |
|---|---|---|---|
| Capsule · Oral | 75 mg | $14.52 per capsule | NDC details & price history |
| Capsule · Oral | 45 mg | $0.787 per capsule | NDC details & price history |
| Powder, For Suspension · Oral | 6 mg/mL | $2.43 per mL | NDC details & price history |
| For Suspension · Oral | 6 mg/mL | $0.150 per mL | NDC details & price history |
| Suspension · Oral | 6 mg/mL | $0.150 per mL | NDC details & price history |
| Suspension · Oral | 30 mg | $0.150 per mL | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC), a survey of retail pharmacy invoice prices. Benchmarks shown are the range across package sizes of a representative product for each form and strength — other manufacturers' products may differ.
Oseltamivir brand names
Oseltamivir is sold under one brand name in the FDA directory — Tamiflu. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.
Who makes Oseltamivir: manufacturers and labelers
36 companies list Oseltamivir products with the FDA. By number of product records, the largest are Proficient Rx LP, A-S Medication Solutions, Amneal Pharmaceuticals NY LLC. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
…and 12 more on the FDA NDC directory.
Oseltamivir drug class (RxNorm)
Oseltamivir belongs to the Neuraminidase Inhibitor class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
Sources for this Oseltamivir page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Amneal Pharmaceuticals NY LLC is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →